ARK Genomic Revolution ETF (ARKG US) stock market data APIs
26.4847
0.24(0.9%)
as of March 16, 2026
Try our APIs with
free plan!
ARK Genomic Revolution ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
26.4847
Open
26.7242
High
27.0415
Low
26.3739
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ARK Genomic Revolution ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ARK Genomic Revolution ETF News
New
Cathie Wood buys $2 million of tumbling AI stock
Cathie Wood, chief of Ark Investment Management, doesn’t give up on her favorite stocks easily. That’s what she just did, buying one of her top holdings that’s down 15% year-to-date. Wood gain...
Cathie Wood’s once upon a time $1,500 Zoom call by 2026 meets reality as software struggles
[Zoom headquarters in Silicon Valley] Sundry Photography Nearly four years after Cathie Wood made one of the most eye-catching forecasts of the pandemic-era technology boom, shares of Zoom Communicat...
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing
Key Points 209,523-share increase in Dyne Therapeutics; estimated transaction value $3.97 million (based on quarterly average pricing) Quarter-end position in Dyne Therapeutics rose $12.82 million in...
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing
Palo Alto Investors LP disclosed an increase of 209,523 shares in Dyne Therapeutics(NASDAQ:DYN) in its 13F filing for the quarter ended December 31, 2025, an estimated $3.97 million trade based on qua...
Get ARK Genomic Revolution ETF fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
